Literature DB >> 16143886

Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.

Yasumi Katsuta1, Xue-Jun Zhang, Masaru Ohsuga, Toshio Akimoto, Hirokazu Komeichi, Shuji Shimizu, Yoshihito Kato, Akiko Miyamoto, Katsuaki Satomura, Teruo Takano.   

Abstract

BACKGROUND: Rats with chronic bile duct ligation (CBDL) and portal vein ligation (PVL) are used as models of portal hypertension. CBDL rats show hypoxemia with intrapulmonary vasodilatation (IPVD), and are recognized as a model of hepatopulmonary syndrome (HPS), while PVL rats are normoxemic. We investigated the differences in arterial oxygenation between these models, and the key factors leading to HPS.
METHODS: Forty-eight Sprague-Dawley rats were prepared as CBDL or PVL models, or as Sham rats. Arterial oxygenation, hemodynamics (reference sample method), and IPVD were simultaneously evaluated in conscious and unrestrained animals, using (141)Ce- or (113)Sn-labeled microspheres (15 microm in diameter), respectively. Endothelin-1 (ET-1) and nitrate/nitrite (end products of nitric oxide; NOx) production by the lung tissue (increment across the lungs) was also determined.
RESULTS: The extent of IPVD was similar in both models, but hypoxemia was only observed in CBDL rats. The ET-1 level and the increment in NOx were significantly increased in CBDL rats, and the increment was directly correlated with impairment of oxygenation. Blood flow through the bronchial arteries (anatomical shunting) was increased in CBDL rats, reaching more than three times the level in PVL rats or Sham rats.
CONCLUSIONS: These results support the hypothesis that NO derived from the lung tissues contributes to hypoxemia, and IPVD appears to be a prerequisite for impaired oxygenation. The considerable increase of anatomical shunting may potentially contribute to impaired oxygenation in CBDL rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143886     DOI: 10.1007/s00535-005-1633-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  31 in total

Review 1.  Pulmonary dysfunction in chronic liver disease.

Authors:  M B Fallon; G A Abrams
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

2.  Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis.

Authors:  Makoto Hosono; Kikuo Machida; Norinari Honda; Takeo Takahashi; Akio Kashimada; Hisato Osada; Osamu Murata; Nobuyuki Ohtawa; Keiichiro Nishimura
Journal:  Ann Nucl Med       Date:  2002-12       Impact factor: 2.668

3.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

4.  Hepatopulmonary syndrome in candidates for liver transplantation.

Authors:  G P Martínez; J A Barberà; J Visa; A Rimola; J C Paré; J Roca; M Navasa; J Rodés; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

5.  Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression.

Authors:  Binay K De; Sambit Sen; Pranab K Biswas; Sanjay K Mandal; Debasish Das; Utpalendu Das; Supriya Guru; Kausik Bandyopadhyay
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

Review 6.  The hepatopulmonary syndrome.

Authors:  P A Lange; J K Stoller
Journal:  Ann Intern Med       Date:  1995-04-01       Impact factor: 25.391

7.  Hypoxaemia and liver cirrhosis: a new argument in favour of a "diffusion-perfusion defect".

Authors:  J B Thorens; A F Junod
Journal:  Eur Respir J       Date:  1992-06       Impact factor: 16.671

8.  Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.

Authors:  Bao Luo; Lichuan Liu; Liping Tang; Junlan Zhang; Cecil R Stockard; William E Grizzle; Michael B Fallon
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

Review 9.  Portopulmonary hypertension and hepatopulmonary syndrome.

Authors:  Marius M Hoeper; Michael J Krowka; Christian P Strassburg
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

10.  Effect of two models of portal hypertension on splanchnic organ blood flow in the rat.

Authors:  D Lebrec; L Blanchet
Journal:  Clin Sci (Lond)       Date:  1985-01       Impact factor: 6.124

View more
  3 in total

Review 1.  Pulmonary complications of hepatic diseases.

Authors:  Salim R Surani; Yamely Mendez; Humayun Anjum; Joseph Varon
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

2.  Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; George Giannakoulas; Theofilos Panagiotidis; Petros Doumtsis; Areti Karasmani; Theodora Oikonomou; Theodora Tzoumari; Haralampos Karvounis; Εvangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2016-12-22

Review 3.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.